dioscin has been researched along with Gouty Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; Jiang, D; Li, F; Li, W; Shi, G; Xie, Y | 1 |
| Li, XZ; Liu, L; Liu, SM; Lu, F; Yu, DH; Zhou, Q | 1 |
2 other study(ies) available for dioscin and Gouty Arthritis
| Article | Year |
|---|---|
Preventive effect of dioscin against monosodium urate-mediated gouty arthritis through inhibiting inflammasome NLRP3 and TLR4/NF-κB signaling pathway activation: an in vivo and in vitro study.
Topics: Animals; Arthritis, Gouty; Diosgenin; Humans; Inflammasomes; Inflammation; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Toll-Like Receptor 4; Uric Acid | 2021 |
Therapeutic effect of Rhizoma Dioscoreae Nipponicae on gouty arthritis based on the SDF-1/CXCR 4 and p38 MAPK pathway: an in vivo and in vitro study.
Topics: Animals; Arthritis, Gouty; Chemokine CXCL12; Dioscorea; Diosgenin; Drugs, Chinese Herbal; Fibroblasts; Interleukin-1beta; Male; MAP Kinase Kinase 3; MAP Kinase Kinase 6; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Receptors, CXCR4; Rhizome; Signal Transduction; Synovial Membrane; Uric Acid | 2014 |